The First Affiliated Hospital of Soochow University
4 clinical trials · 4 recruiting · OTHER
Trials by The First Affiliated Hospital of Soochow University
RECRUITINGPhase 2NCT06429098
Study of A Venetoclax-based, Anthracycline-free Regimen in Newly Diagnosed CBFβ::MYH11(+) AML
This investigator-initiated, single-arm, phase II trial is aimed to evaluate the efficacy and safety of a venetoclax-based, anthracycline-free regimen in patients with newly...
Sponsor: The First Affiliated Hospital of Soochow UniversityEnrolling: 402 locations
Acute Myeloid Leukemia
RECRUITINGPhase 2NCT07159620
Venetoclax Combined With Azacitidine, Chidamide, Vindesine, and Dexamethasone in Newly Diagnosed ETP-ALL Like Patients
ETP-ALL like patients have poor outcomes and prognosis, and the optimal therapeutic approaches are poorly characterized. The goal of this clinical trial is to evaluate the...
Sponsor: The First Affiliated Hospital of Soochow UniversityEnrolling: 271 location
Adult T-cell Leukemia/Lymphoma
RECRUITINGNCT07072221
Bendamustine Combined With Chidamide and Lenalidomide for Relapsed and Refractory PTCL Patients
To evaluate the efficacy and safety of bendamustine combined with chidamide and lenalidomide in R/R PTCL patients.
Sponsor: The First Affiliated Hospital of Soochow UniversityEnrolling: 401 location
Peripheral T-cell Lymphoma
RECRUITINGNCT06125483
TBI/Flu/Bu/Mel Combined With Secondary UCBT in Patients With Hematological Malignancies Who Relapsed After Allo-HSCT
About 33% of patients with myeloid or lymphoid malignancies experience relapse with HLA loss after haplo-HSCT. Due to the specificity of HLA-loss relapse, the 2019 European...
Sponsor: The First Affiliated Hospital of Soochow UniversityEnrolling: 381 location
Hematopoietic MalignancyRelapse/RecurrenceHematopoietic Stem Cell Transplantation